S&P 500: 681.75 +0.1% NASDAQ 100: 601.92 +0.2% Dow Jones: 495.28 +0.1%

Ken Fisher’s RVMD Holdings & Trades

First Buy
Q3 2025
Duration Held
2 Quarters
Largest Add
Q4 2025
+233,752 Shares
Current Position
241,057 Shares
$19.2 M Value

Ken Fisher's RVMD Position Overview

Ken Fisher (via Fisher Asset Management, LLC) currently holds 241,057 shares of Revolution Medicines, Inc. (RVMD) worth $19.2 M, representing 0.01% of the portfolio. First purchased in 2025-Q3, this recently established position has been held for 2 quarters.

Based on recent 13F filings, Ken Fisher has initiated a new position in RVMD, representing a fresh investment thesis on this company. Largest addition occurred in Q4 2025, adding 233,752 shares.

Analysis based on 13F filings available since 2013 Q2

Ken Fisher's Revolution Medicines (RVMD) Holding Value Over Time

Track share changes against reported price movement

Quarterly Revolution Medicines (RVMD) Trades by Ken Fisher

Report Date Bought/Sold (Sh.) % Change Qtr. End Shares Reported Price
Q3 2025 +7,305 New Buy 7,305 $46.70
Q4 2025 +233,752 Add 3199.89% 241,057 $79.65

Ken Fisher's Revolution Medicines Investment FAQs

Ken Fisher first purchased Revolution Medicines, Inc. (RVMD) in Q3 2025, acquiring 7,305 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.

Ken Fisher has held Revolution Medicines, Inc. (RVMD) for 2 quarters since Q3 2025.

Ken Fisher's largest addition to Revolution Medicines, Inc. (RVMD) was in Q4 2025, adding 241,057 shares worth $19.2 M.

According to the latest 13F filing for Q4 2025, Ken Fisher's firm, Fisher Asset Management, LLC, owns 241,057 shares of Revolution Medicines, Inc. (RVMD), valued at approximately $19.2 M.

As of the Q4 2025 filing, Revolution Medicines, Inc. (RVMD) represents approximately 0.01% of Ken Fisher's publicly disclosed stock portfolio, making it one of their key holdings.

Ken Fisher's peak holding in Revolution Medicines, Inc. (RVMD) was 241,057 shares, as reported at the end of Q4 2025.